The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Genotyping Assay Market Research Report 2025
Synopsis
Genotyping assays aim to discriminate between sequences, rather than measure the level of a particular DNA sequence.
The global Genotyping Assay market was valued at US$ 21880 million in 2023 and is anticipated to reach US$ 76560 million by 2030, witnessing a CAGR of 19.3% during the forecast period 2024-2030.
North America is expected to account for the largest market size in the global genotyping assay market during the forecast period, followed by the European region. Increasing adoption of technologically advanced genotyping products, high healthcare expenditure, advanced healthcare infrastructure, highly developed healthcare systems in the U.S. and Canada, numerous genotyping-based R&D projects, and a large number of leading genotyping Presence of manufacturers in the region, along with rising demand for genotyping products from pharmaceutical companies and rising investments by government agencies, are factors that account for a large share of the North America genotyping assay market.
This report aims to provide a comprehensive presentation of the global market for Genotyping Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genotyping Assay.
Report Scope
The Genotyping Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genotyping Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genotyping Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Roche
Qiagen N.V.
Agilent
Fluidigm
Genewiz
Integrated Dna Technologies
Perkinelmer
Bio-Rad Laboratories
Eurofins Scientific
Segment by Type
PCR
Sequencing
Microarray
Others
Segment by Application
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genotyping Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Genotyping assays aim to discriminate between sequences, rather than measure the level of a particular DNA sequence.
The global Genotyping Assay market was valued at US$ 21880 million in 2023 and is anticipated to reach US$ 76560 million by 2030, witnessing a CAGR of 19.3% during the forecast period 2024-2030.
North America is expected to account for the largest market size in the global genotyping assay market during the forecast period, followed by the European region. Increasing adoption of technologically advanced genotyping products, high healthcare expenditure, advanced healthcare infrastructure, highly developed healthcare systems in the U.S. and Canada, numerous genotyping-based R&D projects, and a large number of leading genotyping Presence of manufacturers in the region, along with rising demand for genotyping products from pharmaceutical companies and rising investments by government agencies, are factors that account for a large share of the North America genotyping assay market.
This report aims to provide a comprehensive presentation of the global market for Genotyping Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genotyping Assay.
Report Scope
The Genotyping Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genotyping Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genotyping Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Roche
Qiagen N.V.
Agilent
Fluidigm
Genewiz
Integrated Dna Technologies
Perkinelmer
Bio-Rad Laboratories
Eurofins Scientific
Segment by Type
PCR
Sequencing
Microarray
Others
Segment by Application
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genotyping Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genotyping Assay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 Sequencing
1.2.4 Microarray
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genotyping Assay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmacogenomics
1.3.3 Diagnostic Research
1.3.4 Animal Genetics
1.3.5 Agricultural Biotechnology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genotyping Assay Market Perspective (2019-2030)
2.2 Genotyping Assay Growth Trends by Region
2.2.1 Global Genotyping Assay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genotyping Assay Historic Market Size by Region (2019-2024)
2.2.3 Genotyping Assay Forecasted Market Size by Region (2025-2030)
2.3 Genotyping Assay Market Dynamics
2.3.1 Genotyping Assay Industry Trends
2.3.2 Genotyping Assay Market Drivers
2.3.3 Genotyping Assay Market Challenges
2.3.4 Genotyping Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genotyping Assay Players by Revenue
3.1.1 Global Top Genotyping Assay Players by Revenue (2019-2024)
3.1.2 Global Genotyping Assay Revenue Market Share by Players (2019-2024)
3.2 Global Genotyping Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genotyping Assay Revenue
3.4 Global Genotyping Assay Market Concentration Ratio
3.4.1 Global Genotyping Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genotyping Assay Revenue in 2023
3.5 Genotyping Assay Key Players Head office and Area Served
3.6 Key Players Genotyping Assay Product Solution and Service
3.7 Date of Enter into Genotyping Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genotyping Assay Breakdown Data by Type
4.1 Global Genotyping Assay Historic Market Size by Type (2019-2024)
4.2 Global Genotyping Assay Forecasted Market Size by Type (2025-2030)
5 Genotyping Assay Breakdown Data by Application
5.1 Global Genotyping Assay Historic Market Size by Application (2019-2024)
5.2 Global Genotyping Assay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genotyping Assay Market Size (2019-2030)
6.2 North America Genotyping Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genotyping Assay Market Size by Country (2019-2024)
6.4 North America Genotyping Assay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genotyping Assay Market Size (2019-2030)
7.2 Europe Genotyping Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genotyping Assay Market Size by Country (2019-2024)
7.4 Europe Genotyping Assay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genotyping Assay Market Size (2019-2030)
8.2 Asia-Pacific Genotyping Assay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genotyping Assay Market Size by Region (2019-2024)
8.4 Asia-Pacific Genotyping Assay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genotyping Assay Market Size (2019-2030)
9.2 Latin America Genotyping Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genotyping Assay Market Size by Country (2019-2024)
9.4 Latin America Genotyping Assay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genotyping Assay Market Size (2019-2030)
10.2 Middle East & Africa Genotyping Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genotyping Assay Market Size by Country (2019-2024)
10.4 Middle East & Africa Genotyping Assay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Genotyping Assay Introduction
11.1.4 Illumina Revenue in Genotyping Assay Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Genotyping Assay Introduction
11.2.4 Thermo Fisher Scientific Revenue in Genotyping Assay Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Genotyping Assay Introduction
11.3.4 Roche Revenue in Genotyping Assay Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Qiagen N.V.
11.4.1 Qiagen N.V. Company Detail
11.4.2 Qiagen N.V. Business Overview
11.4.3 Qiagen N.V. Genotyping Assay Introduction
11.4.4 Qiagen N.V. Revenue in Genotyping Assay Business (2019-2024)
11.4.5 Qiagen N.V. Recent Development
11.5 Agilent
11.5.1 Agilent Company Detail
11.5.2 Agilent Business Overview
11.5.3 Agilent Genotyping Assay Introduction
11.5.4 Agilent Revenue in Genotyping Assay Business (2019-2024)
11.5.5 Agilent Recent Development
11.6 Fluidigm
11.6.1 Fluidigm Company Detail
11.6.2 Fluidigm Business Overview
11.6.3 Fluidigm Genotyping Assay Introduction
11.6.4 Fluidigm Revenue in Genotyping Assay Business (2019-2024)
11.6.5 Fluidigm Recent Development
11.7 Genewiz
11.7.1 Genewiz Company Detail
11.7.2 Genewiz Business Overview
11.7.3 Genewiz Genotyping Assay Introduction
11.7.4 Genewiz Revenue in Genotyping Assay Business (2019-2024)
11.7.5 Genewiz Recent Development
11.8 Integrated Dna Technologies
11.8.1 Integrated Dna Technologies Company Detail
11.8.2 Integrated Dna Technologies Business Overview
11.8.3 Integrated Dna Technologies Genotyping Assay Introduction
11.8.4 Integrated Dna Technologies Revenue in Genotyping Assay Business (2019-2024)
11.8.5 Integrated Dna Technologies Recent Development
11.9 Perkinelmer
11.9.1 Perkinelmer Company Detail
11.9.2 Perkinelmer Business Overview
11.9.3 Perkinelmer Genotyping Assay Introduction
11.9.4 Perkinelmer Revenue in Genotyping Assay Business (2019-2024)
11.9.5 Perkinelmer Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Genotyping Assay Introduction
11.10.4 Bio-Rad Laboratories Revenue in Genotyping Assay Business (2019-2024)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Detail
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific Genotyping Assay Introduction
11.11.4 Eurofins Scientific Revenue in Genotyping Assay Business (2019-2024)
11.11.5 Eurofins Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
